- Sponsored Content
- Manufacturing
Security of Supply for Chromatography Media
BPI Contributor
September 18, 2014
1 Min Read
Sponsored by GE HealthCare Technologies
Photo courtesy of AFP PHOTO/JIJI PRESS/TT
This white paper discusses GE Healthcare Life Sciences extensive preventive actions taken to help secure a continuous supply of chromatography media for biopharmaceutical manufacturers.
About the Author(s)
You May Also Like
Upcoming Webcasts
Insider News
Alvotech to manufacture Humira biosimilar for Quallent
May 3, 2024|1 Min ReadOxford Biomedica eyes global market amid hawkish trends
May 2, 2024|2 Min ReadEmergent cuts 300 jobs and shutters two facilities
May 2, 2024|2 Min ReadAsimov says tech increases lentiviral production tenfold
May 2, 2024|2 Min Read
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More